The Board of Directors of Paushak Limited met on January 27, 2026, to approve the unaudited financial results for the quarter ended December 31, 2025, which showed a revenue of ₹61.64 Crores and a net profit of ₹11.23 Crores. The company’s revenue increased by 3.03% on a quarter-on-quarter (QoQ) basis from ₹59.83 Crores in September 2025 and rose by 17.72% year-on-year (YoY) compared to ₹52.36 Crores in December 2024. Net profit for the current quarter grew by 30.43% QoQ from ₹8.61 Crores in the previous quarter but saw a slight decline of 6.65% YoY from ₹12.03 Crores in the corresponding period last year.

Paushak Limited, established in 1972 and part of the 118-year-old Alembic Group, is India’s largest manufacturer of phosgene-based specialty chemicals, serving the pharmaceutical, agrochemical, and performance industries. In recent updates, the company successfully completed a 3:1 bonus issue and a 1:2 stock split in October 2025 to improve market liquidity and participation. Additionally, on January 21, 2026, Paushak announced the commencement of commercial production at its expanded facilities, further strengthening its leadership in specialty phosgene science. Prominent promoters of the company include Nirayu Limited and Alembic Limited, with the promoter group collectively holding 67.28% of the equity as of December 2025.